Genpharmasec (BOM:531592) Valuation Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:531592 Genpharmasec Ltd BOM:531592
56 GF Score
Price ₹1.02
GF Value ₹10.52
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Genpharmasec Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Genpharmasec Valuation Rank Related Terms

BOM:531592
56GF Score
Genpharmasec Ltd BOM:531592
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Genpharmasec (BOM:531592) Overvalued in 2026?

Based on GuruFocus' analysis, Genpharmasec stock appears to be undervalued. The current stock price of ₹1.02 is trading 90.3% below its estimated GF Value™ of ₹10.52. GuruFocus considers Genpharmasec to be Possible Value Trap.

Key valuation signals for BOM:531592:

  • Valuation Rank:
  • GF Value™: ₹10.52 vs. price of ₹1.02 (90.3% below fair value)
  • GF Score™: 56/100 with 5 warning signs

No single metric tells the full story. See the BOM:531592 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Genpharmasec Business Description

Address Akurli Road, Office No. 104 and 105, 1st Floor, Gundecha Industrial Premises Co-op Soc. Ltd., Kandivali (East), Mumbai, MH, IND, 400101
Genpharmasec Ltd is engaged in pharmaceutical activities and services. The company operates in three reportable segments, namely: Diagnostic Pharma Equipment, Trading in Securities, and Laboratory Testing. The company generates the majority of its revenue from the Diagnostic Pharma Equipment Segment. Geographically, the company generates the majority of its revenue from the Domestic market.
56GF Score

Get the complete analysis for BOM:531592

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1.02
Price
₹10.52
GF Value